Cell Based Assays and Bioanalytical Method Development Event

Home

Thank You For Attending!

Assay Stability Immunogenicity Antibody Drug Conjugates Reagents Emerging Technology FDA Guidance

Mark Ma,
AMGEN
Babu Subramanyam
BAYER HEALTHCARE
Mauricio Maia
GENENTECH
 
8 years ago, Biotech industry leaders came to us to establish this industry event years ago and to this day, are still working closely with us to develop a program that they can find anywhere else.
"This event creates opportunities for bioanalytical scientists to share concrete and up-to-date information, which can be immediately beneficial to their daily practices. This is one of the kind event specifically designed for bioanalytical scientists to learn from subject matter experts in the relevant fields."
Mark Ma, Director, Preclinical Research, Amgen
Bioassays 2013 Event Chairman

"IIR's Bioassays and Bioanalytical Method Development Conference provides a focused look into current issues and practices employed in the industry today. No other conference will provide this type of in depth look into the different methodologies and technologies employed by other companies in the field."
Katherine DeDios, Scientist, AMBRX

2013 Highlights Included:

  • Pre- Conference Summit on Current ADC Practices and Technologies and Immunogenicity University
  • Emerging Tech Showcases present up-and-coming technologies to develop and manage your bioassays
  • Interactive Roundtable discussions and session intensives offer a deep dive into those critical pain-points that may stifle productivity
  • Poster Presentations show you the newest research and technologies being developed in bioassays today
PlusBack by Popular Demand! Build your confidence in the foundational day-to-day challenges of immunology at the Immunogenicity University
Home | Contact | download the Agenda | Register| Opt-In
©2013 IIR HOLDINGS, LTD. All Rights Reserved.